Jonathan Olefson - 02 Mar 2022 Form 4 Insider Report for Syneos Health, Inc.

Role
General Counsel & Corp Secty
Signature
/s/ Sara Epstein, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
02 Mar 2022
Net transactions value
-$331,075
Form type
4
Filing time
04 Mar 2022, 16:09:22 UTC
Previous filing
20 Jan 2022
Next filing
21 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SYNH Class A Common Stock Award $0 +5,705 +25% $0.000000 28,882 02 Mar 2022 Direct F1, F2
transaction SYNH Class A Common Stock Award $0 +1,126 +3.9% $0.000000 30,008 02 Mar 2022 Direct F3
transaction SYNH Class A Common Stock Award $0 +1,599 +5.3% $0.000000 31,607 02 Mar 2022 Direct F4
transaction SYNH Class A Common Stock Tax liability $331,075 -4,100 -13% $80.75 27,507 02 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021.
F2 Includes 267 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2022.
F3 Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Compensation and Management Development Committee (the "Committee") of the Board of Directors of Syneos Health, Inc. (the "Issuer") determines the attainment level of the performance goals for the year ended December 31, 2022, subject to continued employment.
F4 Represents performance restricted stock units that were earned based upon performance criteria for the year ended December 31, 2021 and will vest in full once the Committee determines the attainment level of the performance goals for the year ended December 31, 2023, subject to continued employment.